Enjoy complimentary customisation on priority with our Enterprise License!
The adjuvant market size is forecast to increase by USD 2.28 billion at a CAGR of 7.52% between 2023 and 2028. The market's expansion hinges on several critical factors. First, the increase in vaccination initiatives globally is playing a pivotal role in driving market growth as governments and organizations prioritize immunization programs. Second, the escalating prevalence of infectious diseases worldwide has intensified the demand for pharmaceutical and biotechnology solutions, particularly in developing regions. Third, continuous advancements in biotechnology, including innovative drug delivery systems and precision medicine, are reshaping the industry landscape and attracting significant investments.
For more highlights about this market report, Request Free Sample
The adjuvant market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.
The farming segment will account for a major share of the market's growth during the forecast period.?The global market experienced growth in 2022 due to increased usage in farming for enhancing agrochemical efficiency and boosting crop output. Factors driving this trend include the need for sustainable farming methods and the growth of agritourism, advancements in adjuvant compositions, and the expanding global population.
Get a glance at the market share of various regions. Download PDF Sample
The farming segment was valued at USD 2.23 billion in 2018.?In the pharmaceutical and biotechnology sectors, adjuvants are utilized in vaccine production to enhance immunity against various diseases such as influenza, tuberculosis, cholera, polio, measles, malaria, HIV, and TB. However, concerns regarding side effects and high toxicity, particularly with aluminum adjuvanted vaccines, persist. Adjuvant emulsions, pathogen components, saponin-based adjuvants, and particulate adjuvants, and agricultural adjuvants are key segments. Therefore, the demand for adjuvants is expected to increase from the farming application segment, which will drive the growth of the adjuvant market during the forecast period.
For more insights on the market share of various regions, Download PDF Sample now!
North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The market in North America is primarily driven by the healthcare and agriculture sectors. In healthcare, adjuvants such as aluminum hydroxide, oil-based emulsions, bacterial compounds, lipids, and nucleic acids are used to enhance the effectiveness of various types of vaccines, including subunit, recombinant, conjugate, DNA, live attenuated, and inactivated vaccines.
Moreover, these adjuvants boost humoral immunity and T cell responses, increasing vaccine potency. In agriculture, they are utilized to improve the efficiency of organic pesticides and herbicides. Aluminum salts and other they are employed to enhance the performance of these chemicals. Private and public sector investors are investing heavily in adjuvant technologies to develop cutting-edge solutions. Key focus areas include enhancing the efficacy of vaccines against diseases like Respiratory syncytial virus and addressing safety concerns. The market is forecasted to grow under conservative, base, and optimistic scenarios. Key players include those with strong developer and pipeline strengths. Patents play a crucial role in market competition. Hence, such factors will boost adjuvant market growth in this region during the forecast period.
The global market is witnessing significant growth due to the increasing demand for effective vaccines against various diseases such as influenza, tuberculosis, cholera, polio, measles, malaria, HIV, and TB. Adjuvants play a crucial role in enhancing the immune response to vaccine antigens. Diphtheria, Tetanus, and Whooping cough are some diseases for which subunit vaccines and recombinant vaccines are being developed, requiring the use of adjuvants for optimal efficacy. Aluminum hydroxide and aluminum salts are commonly used adjuvants in vaccines due to their ability to stimulate humoral immunity and T cell responses. Other adjuvants include oil-based emulsions, bacterial compounds, and lipids. Private and public sector investors are actively participating in vaccine research, with companies leading the way in developing new assistant technologies. The respiratory syncytial virus is an emerging target for adjuvant development, with aluminum salts and bacterial compounds being explored as potential adjuvants.
Our researchers studied the data for years, with 2022 as the base year and 2023 as the estimated year, and presented the key drivers, trends, and challenges for the market. Our comprehensive report delves into these factors, offering a detailed analysis of the current market scenario. Additionally, we provide a thorough examination of historical data spanning from 2017 to 2021. This historical perspective allows for a deeper understanding of market trends, challenges, and opportunities over the years, providing invaluable insights for stakeholders and decision-makers in the pharmaceutical and biotechnology sectors.
The global market for adjuvants is experiencing significant growth due to the heightened importance of vaccination programs and preventative healthcare, particularly in emerging nations. It plays a crucial role in enhancing vaccine effectiveness by stimulating the immune system, thereby increasing protection against various infectious diseases. The demand for assistant vaccines is increasing as governments prioritize immunization efforts, especially in areas where specific diseases are prevalent, like dengue fever in Southeast Asia and malaria in sub-Saharan Africa.
Moreover, the market encompasses various segments, including aluminium adjuvanted vaccines, Anthrax vaccine, and assistant emulsions. Key adjuvant types include squalene, shark liver oil, saponin-based adjuvants, and particulate adjuvants. These are used in both human and veterinary vaccine production, with applications in diseases such as diphtheria, tetanus, whooping cough, and others. Despite their benefits, it may pose side effects, including swelling and distal paresthesia at injection sites. Hence, such factors are expected to fuel adjuvant market growth during the forecast period.
The market has experienced significant growth due to advancements in nanotechnology, particularly in the creation of adjuvants based on nanoparticles. These innovative assistant enhance vaccine efficacy by precisely delivering antigens to immune cells, resulting in a stronger and more targeted immune response. Many diseases have benefited from these advancements in vaccine production.
However, concerns regarding side effects and high toxicity, often associated with aluminum adjuvanted vaccines, have led government authorities to closely monitor their use. Pharmaceutical and biotechnology companies have responded by developing alternative assistants, such as squalene, shark liver oil, saponin-based adjuvants, and particulate adjuvants, for intramuscular and subcutaneous administration. Hence, the development of nanotechnology is expected to drive adjuvant market growth during the targeted forecast period.
The use of adjuvants in vaccine production for various infectious diseases is crucial. However, safety concerns, such as side effects and high toxicity, can hinder market growth. For instance, the H1N1 influenza pandemic led to increased risks of side effects like narcolepsy and Guillain-Barre syndrome from certain adjuvants like AS03 and Pandemrix. To mitigate such risks, thorough preclinical and clinical assessments are necessary.
Moreover, adjuvants, such as aluminium adjuvanted vaccines, anthrax vaccine, and assistant emulsions segment, are used in the subcutaneous route and can cause swelling and ulnar nerve damage, leading to distal paresthesia. Government authorities and pharmaceutical and biotechnology companies are developing using squalene, shark liver oil, and pathogen components, as well as saponin-based and particulate for intramuscular and subcutaneous administration. Hence, such fctors are hindering adjuvant market growth during the forecast period.
The adjuvant market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the adjuvant market research and growth report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Solvay SA: The company offers adjuvant products such as rainfastness, wetting, compatibility, and other tank mix adjuvants.
The adjuvant market forecast report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Adjuvants are essential components in vaccines and therapeutic proteins, enhancing the immune response to antigens. The global market is witnessing significant growth due to the increasing demand for effective vaccines and therapeutic proteins. The market is driven by factors such as the rising prevalence of infectious diseases, increasing government funding for vaccine research, and technological advancements in Private sector investors and adjuvant development. Cholecystokinin (CCK) and MALP-2 are some of the adjuvants used in vaccines and therapeutic proteins. CCK is a neuropeptide that plays a role in digestion and has been shown to enhance the immune response to antigens.
Moreover, in MALP-2 is a bacterial protein that stimulates the immune system and is used as an adjuvant in various vaccines. The market for adjuvants is segmented based on type, application, and region. The market for adjuvants in therapeutic proteins is expected to grow at a significant rate due to the increasing demand for effective therapeutic proteins. The market for adjuvants in vaccines is also expected to grow at a significant rate due to the increasing demand for effective vaccines. It is competitive, with key players including companies such as DSM, Optimistic track, Seppic, and Invivogen.
However, these companies are investing in research and development to develop new adjuvants and expand their product portfolios. In conclusion, the global market is expected to grow significantly due to the increasing demand for effective vaccines and therapeutic proteins. The market is driven by factors such as the rising prevalence of infectious diseases, increasing government funding for vaccine research, and technological advancements in adjuvant development. The relays market is shaped by evolving forecast scenarios, including base track and conservative track projections. Developer strength and pipeline strength are crucial, influencing advancements. Commercial applications and research applications drive innovation, similar to how vaccine adjuvants impact human and veterinary vaccine development.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
160 |
|
Base year |
2023 |
|
Historic period |
2018 - 2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 7.52% |
|
Market growth 2024-2028 |
USD 2.28 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
6.85 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 41% |
|
Key countries |
US, China, France, Germany, and India |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
BASF SE, BRANDT Inc., Clariant International Ltd., Corteva Inc., Croda International Plc, Dow Chemical Co., GarrCo Products Inc., Huntsman International LLC, Innvictis Crop Care LLC, J.R. Simplot Co., Lamberti SpA, Land O Lakes Inc., Marubeni Corp., Nichino Europe Co. Ltd., Nouryon, Nufarm Ltd., RAG Stiftung, Solvay SA, Stepan Co., and Wilbur Ellis Holdings Inc. |
|
Market dynamics |
Parent market analysis, Market forecasting growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our adjuvant market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
